
E. KORKUSUZ ET AL. 7
17, No. 12, 1998, pp. 2165-2173.
doi:10.1080/07328319808004307
[4] S. L. Janus, A. Z. Magdif, B. P. Erik and N. Claus,
Monatshefte für Chemie/Chemica
1999, 1167.
l Monthly, Vol. 130,
tibacterial Activities,” Medicinal Chemistry
[5] İ. Bildirici, A. Şener and İ. Tozlu, “Further Derivatives of
4-Benzoyl-1,5-Diphenyl-1H-Pyrazole-3-Carboxylic Acid
and Their An
Research, Vol. 16, No. 7-9, 2007, pp. 418-426.
doi:10.1007/s00044-007-9082-z
[6] S. Suzuki and A. Inoue, “Japanese Kokai Tokyo Koho JP
02 172 988 [90172988],” Chemical Abstracts, V
1990, Article ID: 218276.
ol. 113,
nes. 1. Quantitative Structure-
[7] G. J. Hatheway, C. Hansch, K. H. Kim. S. R. Milstein, C.
L. Schimidt, R. N. Smith and F. R. Quin, “Antitumor
1-(X-aryl)-3,3-dialkyltriaze
Activity Relationships vs L1210 Leukemia in Mice,”
Journal of Medical Chemisty, Vol. 21, No. 6, 1978, pp.
563-574. doi:10.1021/jm00204a012
[8] H. Katayama and T. Oshiyama, “Preparation and Bioac-
tivity of Pyrazole Derivatives as Potential Cross-Linking
Agent,” Canadian Journal of Chemistry, Vol. 75, No. 6,
1997, pp. 913-919. doi:10.1139/v97-109
[9] E. Badawey and I. M. El-Ashmawey, “Nonsteroidal Anti-
inflammatory Agents—Part 1: Antiinflammatory, Anal-
gesic and Antipyretic Activity of Some New 1-(Pyrimidin-
2yl)-3-Pyrazolin-5-ones and 2-(Pyrimidin-2-yl)-1,2,4,5,6,
7-Hexahydro-3H-indazol-3-ones,”European Journal of
Medicinal Chemistry, Vol. 33, No. 5, 1998, pp. 349-361.
doi:10.1016/S0223-5234(98)80002-0
[10] O. Bruno, A. Ranise, F. Bondavalli, P. Schenone and M.
D’amico, Farmaco 47, 1992, p. 1235.
[11] P. D. Mishra, S. Wahidullah and S. Y. Kamat, Indian
Journal of Chemistry, Vol. B 37, 1998, p. 199.
W. T. Thomson, “Agricultural C[12] hemicals-Book II:
Herbicides,” 13th Edition, Thomson Publications, Fresno,
1997, pp. 268-278.
[13] M. Londershausen, “Review: Approaches to New Para-
siticides,” Pesticide Science, Vol. 48, No. 4, 1996, pp.
269-292.
doi:10.1002/(SICI)1096-9063(199612)48:4<269::AID-PS
478>3.0.CO;2-B
[14] H. S. Chen and Z. M. Li, Chemical Journal of Chinese
Universities, Vol. 19, 1998, p. 572.
[15] M. Kurowaski, A. Dunky and M. Geddawi, European
Journal of Clinical Pharmacology, Vol. 307, 1987, p. 31.
[16] F. Lepage, B. Hublot, Eur. Pat. Appl. EP.459, 887;
Chemical Abstracts, Vol. 116, 1992, 128917.
[17] D. M. Bailey, P. E. Hansen, A. G. Hlavac, E. R. Baizman,
J. Pearl, A. F. Defelice and M. E. Feigenson, “3,4-Di-
phenyl-1H-pyrazole-1-propanamine Antidepressants,” Jour-
nal of Medical Chemisty, Vol. 28, No. 2, 1985, pp. 256-
260. doi:10.1021/jm00380a020
[18] R. H. Wiley and P. Wiley, “Pyrazolones, Pyrazolidones
and Derivatives,” John Wiley and Sons, New York, 1964,
p. 102.
[19] E. E. Baroni and K. A. Kovyrzina, Zhurnal Obshchei
Khim, Vol. 31, 1961, p. 1641.
shi, S. Inami, Y. Yanase, N. Tomura, J. Kishi and
tionen
[20] S. Ohuchi, S. Okada, CA 130, 120912, JP 10338589,
1998.
[21] Y. Yoshikawa, K. Tomiya, T. Kitajima, H. Katsuta, O.
Takaha
H. Kawasima, CA 129, 16051, EP 841336 (1998).
[22] E. Ziegler, M. Eder, C. Belegratis, and E. Prewedourakis,
“Synthesen von Heterocyclen, 103. Mitt.: Über Reak
mit Oxalylchlorid (Kurze Mitteilung),” Monatshefte für
Chemie/Chemical Monthly, Vol. 98, No. 6, 1967, pp.
2249-2251. doi:10.1007/BF00902421
[23] G. Kollenz, C. O. Kappe and H. A. El Nabey, “On the Reac-
tion of 2,2,6,6-Tetramethyl-3,5-heptanedione (‘Dipivaloyl-
methane’) with Oxalyl Chloride,” Heterocycles, Vol. 32,
No. 4, 1991, pp. 669-673. doi:10.3987/COM-91-5679
[24] İ. Ö. İlhan, E. Sarıpınar and Y. Akçamur, Journal of Het-
erocyclic Chemistry, Vol. 42, 2005, p. 117.
[25] İ. Yıldırım, F. Kandemirli and Y. Akçamur, “Experimen-
tal and Quantum-Chemical Calculations on Some 1H-
pyrazole-3-carboxamide and -3-Carboxylate Derivatives
Formation,” Journal of Molecular Structure, Vol. 738,
No. 1-3, 2005, pp. 275-279.
doi:10.1016/j.molstruc.2004.12.026
[26] İ. Yıldırım and F. Kandemir
retical Studies on the Functionaliz
li, “Experimental and Theo-
ation Reactions of
4-Benzoyl-1,5-diphenyl-1H-pyrazole-3-carboxylic Acid
and-Acid Chloride with Various Aminophenols,” Struc-
tural Chemistry, Vol. 17, No. 2, 2006, pp. 241-247.
doi:10.1007/s11224-006-9052-y
[27] Y. Akçamur, G. Penn, E. Ziegler, H. Sterk, G. Kolle
Peters, E. M. Peters and H. G.
nz, K.
von Schnering, “Reak-
tionen mit Cyclischen Oxalylverbindungen, XXIV. Zur
Reaktion von 4-Benzoyl-5-phenyl-furan-2,3-dion mit Phe-
nylhydrazonen bzw. Phenylhydrazin,” Monatshefte Für
Chemie/Chemical Monthly, Vol. 117, No. 2, 1986, pp.
231-245. doi:10.1007/BF00809443
[28] Y. Akçamur, A. Şener, A. M. Ipekoglu and G. Kollenz,
Journal of Heterocyclic Chemistry, Vol. 34, 1997, p. 221.
Nitriles under Mild Conditions by an
[29] A. Şener, R. Kasımogulları, M. K. Şener, I. Bildirici and
Y. Akçamur, Journal of Heterocyclic Chemistry, Vol. 39,
2002, p. 869.
[30] M. A. Cohen, J. Sawden and N. J. Turner, “Selective
Hydrolysis of
Enzyme,” Tetrahedron Letters, Vol. 31, No. 49, 1990,
7223-7226. doi:10.1016/S0040-4039(00)97285-X
[31] M. E. Fabiani, Drug News & Perspectives, Vol. 12, 1999,
pp. 207.
[32] F. F. Fleming, L. Yao, P. C. Ravikumar, L. Funk and B.
C. Shook, Journal of Medical Chemisty, Vol. 53, No. 22,
Structure Solution and Refinement,”
2010, pp. 7902-7917.
[33] Rigaku/MSC, Inc., 9009 new Trails Drive, The Wood-
lands, TX 77381.
[34] G. M. Sheldrick, “SHELXS-97 and SHELXL-97, Pro-
gram for Crystal
University of Göttingen, 1997.
[35] L. Infants, C. Foces-Foces, R. M. Claramunt, C. Lopez
Copyright © 2012 SciRes. CSTA